Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines

In early 2007, the Indonesian government decided to withhold its bird flu virus samples from WHO’s collaborating centres pending a new global mechanism for virus sharing that had better terms for developing countries. The 60th World Health Assembly subsequently resolved to establish an international...

Full description

Bibliographic Details
Main Authors: CHAN Chee Khoon, Gilles de Wildt
Format: Report
Language:unknown
Subjects:
Avian flu
Online Access:http://www.un.org/esa/desa/papers/2007/wp41_2007.pdf
id ftrepec:oai:RePEc:une:wpaper:41
record_format openpolar
spelling ftrepec:oai:RePEc:une:wpaper:41 2023-05-15T15:34:13+02:00 Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines CHAN Chee Khoon Gilles de Wildt http://www.un.org/esa/desa/papers/2007/wp41_2007.pdf unknown http://www.un.org/esa/desa/papers/2007/wp41_2007.pdf preprint ftrepec 2020-12-04T13:36:56Z In early 2007, the Indonesian government decided to withhold its bird flu virus samples from WHO’s collaborating centres pending a new global mechanism for virus sharing that had better terms for developing countries. The 60th World Health Assembly subsequently resolved to establish an international stockpile of avian flu vaccines, and mandated WHO to formulate mechanisms and guidelines for equitable access to these vaccines. Are there analogous opportunities for study volunteers or donors of biological materials in clinical trials or other research settings to exercise corresponding leverage to advance health equity? avian flu vaccines, global health equity, international health security, essential medicines, public patents Report Avian flu RePEc (Research Papers in Economics)
institution Open Polar
collection RePEc (Research Papers in Economics)
op_collection_id ftrepec
language unknown
description In early 2007, the Indonesian government decided to withhold its bird flu virus samples from WHO’s collaborating centres pending a new global mechanism for virus sharing that had better terms for developing countries. The 60th World Health Assembly subsequently resolved to establish an international stockpile of avian flu vaccines, and mandated WHO to formulate mechanisms and guidelines for equitable access to these vaccines. Are there analogous opportunities for study volunteers or donors of biological materials in clinical trials or other research settings to exercise corresponding leverage to advance health equity? avian flu vaccines, global health equity, international health security, essential medicines, public patents
format Report
author CHAN Chee Khoon
Gilles de Wildt
spellingShingle CHAN Chee Khoon
Gilles de Wildt
Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines
author_facet CHAN Chee Khoon
Gilles de Wildt
author_sort CHAN Chee Khoon
title Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines
title_short Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines
title_full Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines
title_fullStr Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines
title_full_unstemmed Developing Countries, Donor Leverage, and Access to Bird Flu Vaccines
title_sort developing countries, donor leverage, and access to bird flu vaccines
url http://www.un.org/esa/desa/papers/2007/wp41_2007.pdf
genre Avian flu
genre_facet Avian flu
op_relation http://www.un.org/esa/desa/papers/2007/wp41_2007.pdf
_version_ 1766364703306547200

Similar Items